Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status

被引:0
作者
M Ruella
A Rocci
I Ricca
C Carniti
C Labetti Bodoni
M Ladetto
D Caracciolo
M Boccadoro
C Carlo-Stella
P Corradini
C Tarella
机构
[1] Università di Torino,Dipartimento di Medicina ed Oncologia Sperimentale, Divisione di Ematologia
[2] Ospedale Cottolengo,Division Medicina Generale
[3] Molecular Biotechnology Center—Università di Torino,undefined
[4] Hematology—BMT Unit,undefined
[5] Istituto Nazionale dei Tumori,undefined
[6] Oncologia Medica,undefined
[7] Istituto Nazionale dei Tumori,undefined
[8] SCDU Ematologia e Terapie Cellulari,undefined
[9] AO Mauriziano – Umberto I,undefined
来源
Bone Marrow Transplantation | 2010年 / 45卷
关键词
hematopoietic SCT; cell aging; senescence; telomere; high-dose chemotherapy; rejuvenation;
D O I
暂无
中图分类号
学科分类号
摘要
Our objective was to characterize the role of grafted cells in determining telomere length (TL) after hematopoietic SCT (HSCT). A total of 20 patients undergoing autografts had PBSC collected after two sequential mobilization courses: TL in the first collection was significantly longer than in the second. For their autografts, 10 patients used PBSC from the first collection and 10 from the second. TL was also investigated before and after HSCT and on the graft in 10 allogeneic HSCT. After autografting, patients receiving PBSC from the first collection had BM TL reflecting that of grafted cells (median bp: 7730 on PBSC vs 7610 on post-HSCT BM, P=NS) and significantly longer than TL of the second collection; analogously, patients autografted with PBSC from the second collection had BM TL reflecting that of grafted cells (7360 on PBSC vs 7120 on post-HSCT BM, P=NS) and significantly shorter compared with the first collection. In the allograft setting, eight patients had their pre-transplant TL significantly shorter than donor PBSC (5960 vs 7110; P=0.0005); following HSCT, BM TL (median 7380 bp) was identical to that of the graft (P=NS). We conclude that grafted cells have a major role in determining TL after HSCT.
引用
收藏
页码:505 / 512
页数:7
相关论文
共 256 条
[1]  
Blackburn EH(1991)Structure and function of telomeres Nature 350 569-573
[2]  
Zakian VA(1995)Telomeres: beginning to understand the end Science 270 1601-1607
[3]  
Van Steensel B(1998)TRF2 protects human telomeres from end-to-end fusions Cell 92 401-413
[4]  
Smogorzewska A(1999)Mammalian telomeres end in a large duplex loop Cell 97 503-514
[5]  
deLange T(2008)Telomeres, stem cells and hematology Blood 111 1759-1766
[6]  
Griffith JD(1990)Structure and variability of human chromosome ends Mol Cell Biol 10 518-527
[7]  
Comeau L(2000)Accumulation of short telomeres in human fibroblasts prior to replicative senescence Exp Cell Res 256 291-299
[8]  
Rosenfield S(1990)Telomeres, telomerase and senescence Bioassays 12 363-369
[9]  
Stansel RM(1991)Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256 271-282
[10]  
Bianchi A(1991) loss of telomeric repeats with age in humans Mutat Res 256 45-48